tiprankstipranks
Gain Therapeutics (GANX)
NASDAQ:GANX
US Market
GANX
Gain Therapeutics
RESEARCH TOOLSreports

Gain Therapeutics (GANX) Cash flow

431 Followers

Gain Therapeutics Cash Flow

GANX's free cash flow for Q4 2025 was $-4.62M. For the 2025 fiscal year, GANX's free cash flow was decreased by $430.89K and operating cash flow was $-4.62M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -18.47M$ -18.87M$ -18.87M$ -14.69M$ -12.37M
Investing Cash Flow
$ 0.00$ 4.98M$ 10.22M$ -14.77M$ -94.21K
Financing Cash Flow
$ 28.45M$ 13.01M$ 12.64M$ -78.77K$ 41.77M
End Cash Position
$ 20.87M$ 10.42M$ 11.83M$ 7.34M$ 36.91M
Free Cash Flow
$ -18.47M$ -18.90M$ -18.88M$ -14.81M$ -12.46M
Currency in USD

Gain Therapeutics Cash Flow